Regulation of the immune response during infectious myocarditis

References

• Veinot JP. Endomyocardial biopsy-when and how? Cardiovasc Pathol 2010;20(5):291-6
   Google Scholar
• Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 2004;180(3):110-12
   PubMed Web of Science ®Google Scholar
• Felker GM, Hu W, Hare JM, et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine 1999;78(4):270-83
   PubMed Web of Science ®Google Scholar
• Bowles NE, Vallejo J. Viral causes of cardiac inflammation. Curr Opin Cardiol 2003;18(3):182-8
   Google Scholar
• Andreoletti L, Leveque N, Boulagnon C, et al. Viral causes of human myocarditis. Arch Cardiovasc Dis 2009;102(6-7):559-68
   Google Scholar
• Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 2007;41(1):118-22
   Google Scholar
• Coronado MJ, Brandt JE, Kim E, et al. Testosterone and interleukin-1beta increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol 2012;302(8):H1726-36
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002;4(4):411-17
   Google Scholar
• Li K, Xu W, Guo Q, et al. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 2009;105(4):353-64
   Google Scholar
• Cao Y, Xu W, Xiong S. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. PLoS One 2013;8(9):e74955
   PubMed Web of Science ®Google Scholar
• Huber SA, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 2006;99(10):1109-16
   Google Scholar
• Lv K, Xu W, Wang C, et al. Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells. Clin Immunol 2011;140(1):92-101
   Google Scholar
• Mariano FS, Gutierrez FR, Pavanelli WR, et al. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 2008;10(7):825-33
   PubMed Web of Science ®Google Scholar
• Abston ED, Coronado MJ, Bucek A, et al. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol 2012;2012:129486
   PubMedGoogle Scholar
• Rangachari M, Mauermann N, Marty RR, et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006;203(8):2009-19
   PubMed Web of Science ®Google Scholar
• D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85(5):499-504
   Google Scholar
• Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis 2010;52(4):274-88
   PubMed Web of Science ®Google Scholar
• Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006;113(6):876-90
   PubMed Web of Science ®Google Scholar
• Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 2003;60(1):5-10
   Google Scholar
• Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 2005;15(1):17-27
   PubMed Web of Science ®Google Scholar
• Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18(6):619-24
   PubMed Web of Science ®Google Scholar
• Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113(4):593-5
   PubMed Web of Science ®Google Scholar
• Andreoletti L, Bourlet T, Moukassa D, et al. Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy. J Infect Dis 2000;182(4):1222-7
   Google Scholar
• Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001;11(6):355-68
   PubMed Web of Science ®Google Scholar
• Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008;118(6):639-48
   PubMed Web of Science ®Google Scholar
• Cooper LT Jr. Myocarditis. N Engl J Med 2009;360(15):1526-38
   PubMed Web of Science ®Google Scholar
• Rahman JE, Helou EF, Gelzer-Bell R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43(3):410-15
   PubMed Web of Science ®Google Scholar
• Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 2004;43(12):2305-13
   PubMed Web of Science ®Google Scholar
• Basso C, Ronco F, Marcus F, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 2008;29(22):2760-71
   PubMed Web of Science ®Google Scholar
• Bowles NE, Ni J, Marcus F, Towbin JA. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2002;39(5):892-5
   Google Scholar
• Andreoletti L, Venteo L, Douche-Aourik F, et al. Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol 2007;50(23):2207-14
   Google Scholar
• Wang TY, AlJaroudi WA, Newby LK. Markers of cardiac ischemia and inflammation. Cardiol Clin 2005;23(4):491-501. vi
   Google Scholar
• Klingel K, Kandolf R. Osteopontin: a biomarker to predict the outcome of inflammatory heart disease. Semin Thromb Hemost 2010;36(2):195-202
   Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science 2002;296(5566):301-5
   PubMed Web of Science ®Google Scholar
• Richer MJ, Lavallee DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 2009;4(1):e4127
   PubMed Web of Science ®Google Scholar
• Boyd JH, Mathur S, Wang Y, et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res 2006;72(3):384-93
   Google Scholar
• Richer MJ, Fang D, Shanina I, Horwitz MS. Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol 2006;121(3):339-49
   Google Scholar
• Gorbea C, Makar KA, Pauschinger M, et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 2010;285(30):23208-23
   PubMed Web of Science ®Google Scholar
• Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6(10):981-8
   PubMed Web of Science ®Google Scholar
• Wessely R, Klingel K, Knowlton KU, Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 2001;103(5):756-61
   PubMed Web of Science ®Google Scholar
• Brencicova E, Diebold SS. Nucleic acids and endosomal pattern recognition: how to tell friend from foe? Front Cell Infect Microbiol 2013;3:37
   PubMed Web of Science ®Google Scholar
• Riad A, Westermann D, Escher F, et al. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am J Physiol Heart Circ Physiol 2010;298(6):H2024-31
   Google Scholar
• Fuse K, Chan G, Liu Y, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 2005;112(15):2276-85
   PubMed Web of Science ®Google Scholar
• Bafica A, Santiago HC, Goldszmid R, et al. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 2006;177(6):3515-19
   PubMed Web of Science ®Google Scholar
• Caetano BC, Carmo BB, Melo MB, et al. Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi. J Immunol 2011;187(4):1903-11
   Google Scholar
• Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 2009;33(3-4):222-30
   PubMed Web of Science ®Google Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11(10):889-96
   PubMed Web of Science ®Google Scholar
• Frisancho-Kiss S, Coronado MJ, Frisancho JA, et al. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun 2009;23(5):649-57
   PubMed Web of Science ®Google Scholar
• Bastos KR, Alvarez JM, Marinho CR, et al. Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J Leukoc Biol 2002;71(2):271-8
   Google Scholar
• Cuervo H, Guerrero NA, Carbajosa S, et al. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 2011;187(5):2656-65
   Google Scholar
• Kitaura-Inenaga K, Hara M, Higuchi K, et al. Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ J 2003;67(10):881-4
   Google Scholar
• Higuchi H, Hara M, Yamamoto K, et al. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 2008;118(4):363-72
   Google Scholar
• Case LK, Moussawi M, Roberts B, et al. Histamine H(1) receptor signaling regulates effector T cell responses and susceptibility to coxsackievirus B3-induced myocarditis. Cell Immunol 2012;272(2):269-74
   Google Scholar
• Szalay G, Sauter M, Hald J, et al. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 2006;169(6):2085-93
   Google Scholar
• Nishii M, Inomata T, Takehana H, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004;44(6):1292-7
   PubMed Web of Science ®Google Scholar
• Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 2009;84(11):1001-9
   PubMed Web of Science ®Google Scholar
• Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30(16):1995-2002
   PubMed Web of Science ®Google Scholar
• Cooper LT. The heat is off: immunosuppression for myocarditis revisited. Eur Heart J 2009;30(16):1936-9
   Google Scholar
• Ellis CR, Di Salvo T. Myocarditis: basic and clinical aspects. Cardiol Rev 2007;15(4):170-7
   PubMedGoogle Scholar
• Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333(5):269-75
   PubMedGoogle Scholar
• Matsumori A. Treatment options in myocarditis: what we know from experimental data and how it translates to clinical trials. Herz 2007;32(6):452-6
   Google Scholar
• Okura Y, Takeda K, Honda S, et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 1998;82(10):1035-42
   PubMed Web of Science ®Google Scholar
• Okura Y, Yamamoto T, Goto S, et al. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997;29(2):491-502
   PubMed Web of Science ®Google Scholar
• Damsker JM, Hansen AM, Caspi RR. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 2010;1183:211-21
   PubMed Web of Science ®Google Scholar
• Fairweather D, Frisancho-Kiss S, Yusung SA, et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 2004;165(6):1883-94
   PubMed Web of Science ®Google Scholar
• Barin JG, Talor MV, Baldeviano GC, et al. Mechanisms of IFNgamma regulation of autoimmune myocarditis. Exp Mol Pathol 2010;89(2):83-91
   Google Scholar
• Yuan J, Yu M, Lin QW, et al. Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis. Int Immunopharmacol 2010;10(3):272-6
   Google Scholar
• da Matta Guedes PM, Gutierrez FR, Maia FL, et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 2010;4(2):e604
   PubMed Web of Science ®Google Scholar
• Xie Y, Chen R, Zhang X, et al. The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. Virology 2011;421(1):78-84
   Google Scholar
• Shi Y, Fukuoka M, Li G, et al. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Circulation 2010;121(24):2624-34
   Google Scholar
• Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000;35(6):1590-8
   Google Scholar
• Felix SB, Staudt A. Immunoadsorption as treatment option in dilated cardiomyopathy. Autoimmunity 2008;41(6):484-9
   PubMed Web of Science ®Google Scholar
• Seko Y, Yagita H, Okumura K, et al. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Cardiovasc Res 2007;75(1):158-67
   Google Scholar
• Gutierrez FR, Mariano FS, Oliveira CJ, et al. Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. (PD-1). Infect Immun 2011;79(5):1873-81
   PubMed Web of Science ®Google Scholar
• Eriksson U, Kurrer MO, Schmitz N, et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003;107(2):320-5
   Google Scholar
• Cunha-Neto E, Nogueira LG, Teixeira PC, et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 2009;104(Suppl 1):252-8
   PubMedGoogle Scholar
• Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97(14):1382-91
   PubMed Web of Science ®Google Scholar
• Lisman KA, Stetson SJ, Koerner MM, et al. Managing heart failure with immunomodulatory agents. Cardiol Clin 2001;19(4):617-25
   Google Scholar
• Torre-Amione G, Kapadia S, Lee J, et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92(6):1487-93
   PubMed Web of Science ®Google Scholar
• Francis SE, Holden H, Holt CM, Duff GW. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1998;30(2):215-23
   Google Scholar
• Petersen CA, Burleigh BA. Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infect Immun 2003;71(8):4441-7
   Google Scholar
• Shoji-Kawata S, Levine B. Autophagy, antiviral immunity, and viral countermeasures. Biochim Biophys Acta 2009;1793(9):1478-84
   PubMed Web of Science ®Google Scholar
• Spiroska V, Kedev S, Antov S, et al. Association between 22 cytokine gene polymorphisms and dilated cardiomyopathy in Macedonian patients. Kardiol Pol 2009;67(11):1237-47
   Google Scholar
• Xu L, Kitani A, Strober W. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol 2010;3(3):230-8
   Google Scholar
• Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7(10):827-40
   PubMed Web of Science ®Google Scholar
• Abston ED, Barin JG, Cihakova D, et al. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ Heart Fail 2012;5(3):366-75
   Google Scholar
• Sesti-Costa R, Silva GK, Proenca-Modena JL, et al. The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J Immunol 2013;191(1):283-92
   Google Scholar
• Shen Y, Xu W, Chu YW, et al. Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 2004;78(22):12548-56
   Google Scholar
• Goser S, Ottl R, Brodner A, et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 2005;112(22):3400-7
   Google Scholar
• Marino AP, da Silva A, dos Santos P, et al. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 2004;110(11):1443-9
   PubMed Web of Science ®Google Scholar
• DeBiasi RL, Robinson BA, Leser JS, et al. Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail 2010;16(11):901-10
   Google Scholar
• Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000;102(23):2829-35
   Google Scholar
• Borger P, Hoekstra Y, Esselink MT, et al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol 1998;19(3):400-7
   Google Scholar
• Panina-Bordignon P, Mazzeo D, Lucia PD, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997;100(6):1513-19
   PubMed Web of Science ®Google Scholar
• Nishii M, Inomata T, Niwano H, et al. Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 2006;114(9):936-44
   Google Scholar
• Aoki MP, Carrera-Silva EA, Cuervo H, et al. Nonimmune cells contribute to crosstalk between immune cells and inflammatory mediators in the innate response to trypanosoma cruzi infection. J Parasitol Res 2012;2012:737324
   Google Scholar
• Marchant D, McManus BM. Matrix metalloproteinases in the pathogenesis of viral heart disease. Trends Cardiovasc Med 2009;19(1):21-6
   Google Scholar
• Hishikari K, Watanabe R, Ogawa M, et al. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 2010;96(7):523-7
   Google Scholar
• Westermann D, Savvatis K, Schultheiss HP, Tschope C. Immunomodulation and matrix metalloproteinases in viral myocarditis. J Mol Cell Cardiol 2010;48(3):468-73
   PubMed Web of Science ®Google Scholar
• Cheung C, Marchant D, Walker EK, et al. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 2008;117(12):1574-82
   PubMed Web of Science ®Google Scholar
• Heymans S, Pauschinger M, De Palma A, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 2006;114(6):565-73
   PubMed Web of Science ®Google Scholar
• Li J, Schwimmbeck PL, Tschope C, et al. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc Res 2002;56(2):235-47
   Google Scholar
• Lang C, Sauter M, Szalay G, et al. Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med 2008;86(1):49-60
   Google Scholar
• Gutierrez FR, Lalu MM, Mariano FS, et al. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis 2008;197(10):1468-76
   Google Scholar
• Azuma RW, Suzuki J, Ogawa M, et al. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. Cardiovasc Res 2004;64(3):412-20
   Google Scholar
• Melo L, Caldas IS, Azevedo MA, et al. Low Doses of Simvastatin Therapy Ameliorate Cardiac Inflammatory Remodeling in Trypanosoma cruzi-Infected Dogs. Am J Trop Med Hyg 2011;84(2):325-31
   Google Scholar
• Forero-Pena DA, Gutierrez FRS. Statins as Modulators of Regulatory T-Cell Biology. Mediat Inflamm 2013;2013:167086
   PubMed Web of Science ®Google Scholar
• Wei L, Wei-Min L, Cheng G, Bao-Guo Z. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis. Autoimmunity 2006;39(4):289-98
   PubMedGoogle Scholar